Recurrent Oropharyngeal Squamous Cell Carcinoma Active Not Recruiting Phase 3 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0037158 (Recurrent Oropharyngeal Squamous Cell Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00588770Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTreatment